Isaac Ebiju
ID: UNCST-2024-R003903
|
Assessing the Impact of Summary Clinical Guidelines (charts and wheels) on Rational Antibiotic Use and Compliance with Uganda Clinical Guidelines Among Outpatient Prescribers: A case study of Health Centres III & IV in Kampala, Uganda.
REFNo: HS4926ES
To assess the impact and sustainability of summary clinical guidelines for improving compliance of prescription patterns with treatment guidelines on antibiotic use among prescribers at health Centers III and IV in Kampala, Uganda.,To analyze factors affecting guideline utilization among prescribers at health Centers III and IV in Kampala, Uganda.,To assess the compliance and prescription patterns of the Uganda Clinical Guidelines by prescribers at health Centers III and IV in Kampala, Uganda. ,To determine if the use of summary clinical guidelines improves the rational use of antibiotics and adherence to Uganda clinical guidelines among prescribers in outpatient departments of Health Centre IIIs and IVs in Kampala, Uganda.,
|
Uganda |
2024-10-14 8:08:10 |
2027-10-14 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Thereza Piloya Were
ID: UNCST-2019-R000491
|
Effects of Social Determinants of Health on Type 1 Diabetes (T1D) Care in Sub Saharan Africa; Perspectives from Uganda.
REFNo: HS5008ES
Primary
i. To describe the SDOH among the children and youths in Uganda.
ii. To determine the impact of SDoH on glycemic control of children and youths aged 6 months- 25 years in Uganda.
iii. To determine the effect of the SDoH on the physical growth of children and youths in Uganda.
Secondary
i. To set up a database of SDoH for children with T1D in Uganda.
ii. To determine the effect of the SDoH on the complications (DKA, severe hypoglycemia and hypertension) of children and youths in Uganda.
|
Uganda |
2024-10-14 8:06:50 |
2027-10-14 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Cissy Kityo
ID: UNCST-2021-R013663
|
Impact of Non-B HIV-1 Subtype on second-line Protease Inhibitor Regimens in Africa (INSPIRE)
REFNo: HS5035ES
To evaluate the effect of replicative fitness on susceptibility to PIs in patients with repeated failure in presence of known and novel Gag and Env PI-associated mutations.,To assess HIV-1 drug resistance in PI-resistant viruses using phenotypic drug susceptibility assay and recombinant viruses based on gag, pol, and env genes derived from patients failing 2L.,To determine the basis for second line (2L) treatment failures on ATV/r- and LPV/r-containing regimens in the absence and presence of protease-associated drug resistance.,To determine the effect of Non-B HIV-1 Subtype on second-line Protease Inhibitor Regimens in Africa.,
|
Uganda |
2024-10-14 8:03:22 |
2027-10-14 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Benjamin Eyre
ID: UNCST-2024-R002750
|
Enumerating development: how interdisciplinary perspectives on the treatment of research officers can improve data for social transformation
REFNo: SS3327ES
To generate new knowledge on FOs perspectives in relation to their work practices and conditions with a particular focus on how they see this affecting the quality of the data they produce. ,To explore challenges FOs negotiate, including low salaries, precarious employment contracts, pressure to perform quickly, working in dangerous environments, and negotiating knowledge hierarchies.,To document the lived experience of FOs working in the behavioural economics research sector in Uganda. Their work involves conducting surveys, experiments, and RCTs in informal urban settlements, peri-urban, and rural areas. ,
|
UK |
2024-10-14 8:02:17 |
2027-10-14 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Rosalind Parkes-Ratanshi Parkes
ID: UNCST-2019-R000717
|
Providing Rapid HIV viral Diagnostics at Point of Care (The PROmPT) study.
REFNo: HS4881ES
Primary:
To evaluate quantitative performance of the HIV self-testing platform in a resource-limited setting (Uganda) compared to a laboratory-based, gold-standard FDA-approved HIV VL test (Roche Cobas Quantitative HIV-1 RNA, or Abbott Real Time HIV-1 assay, or similar) in PLHIV who have both viral suppression and non-suppression.
Secondary:
To evaluate patient acceptability of the HIV self-testing platform compared to gold standard VL assay
To compare the Turnaround Time (TaT) of the HIV VL self-testing assay and lab-based VL assay
To compare the assay performance of the HIV self-testing platform to lab-based testing by sex, age group, HIV viral load, HIV clade, and HIV risk group
|
UK |
2024-10-08 18:13:17 |
2027-10-08 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|